Insiders Advisor
  • Stocks
  • World News
  • Business
  • Politics
  • Stocks
  • World News
  • Business
  • Politics

Insiders Advisor

Stocks

Biotechs Fall Apart with Dark Cross Neutral Signal

by November 15, 2024
November 15, 2024
Biotechs Fall Apart with Dark Cross Neutral Signal

(This is an excerpt from the subscriber-only DP Weekly Wrap for Friday)

Friday, the Biotechnology ETF (IBB) 20-day EMA crossed down through the 50-day EMA (Dark Cross), above the 200-day EMA, generating an IT Trend Model NEUTRAL Signal. IBB recently switched to a BUY Signal on Friday November 8 and we said at the time, “IBB is approaching the top of a four-month trading range (resistance), so this BUY Signal doesn’t look very juicy at this time.” This emphasizes why we consider Trend Model signals to be information flags, not action commands. Always check the chart.

Part of the reason Biotechs fell apart was the nomination of Robert F. Kennedy Jr. to the Health and Human Services department. He is known to be anti-COVID vaccines and just generally not a fan of chemicals for the body. This doesn’t necessarily bode well for this industry.

Participation has been plummeting as more and more stocks lose support at key moving averages. This drop below the 200-day EMA is perilous and given the negative indicators, the decline isn’t likely over yet. The PMO is dropping below the zero line on a Crossover SELL Signal and Stochastics are below 20 signaling extreme weakness. Support is arriving around 130.00, but it doesn’t look good.

The weekly chart shows the breakdown from the rising wedge formation, which is the normal resolution from this formation. The weekly PMO is tumbling lower. Support on the weekly chart is around 123.00. That would be a painful decline added to this already deep decline.

Introducing the new Scan Alert System!

Delivered to your email box at the end of the market day. You’ll get the results of our proprietary scans that Erin uses to pick her “Diamonds in the Rough” for the DecisionPoint Diamonds Report. Get all of the results and see which ones you like best! Only $29/month! Or, use our free trial to try it out for two weeks using coupon code: DPTRIAL2. Click HERE to subscribe NOW!

Learn more about DecisionPoint.com:

Watch the latest episode of the DecisionPointTrading Room on DP’s YouTube channel here!

Try us out for two weeks with a trial subscription!

Use coupon code: DPTRIAL2 Subscribe HERE!

Technical Analysis is a windsock, not a crystal ball. –Carl Swenlin

(c) Copyright 2024 DecisionPoint.com

Disclaimer: This blog is for educational purposes only and should not be construed as financial advice. The ideas and strategies should never be used without first assessing your own personal and financial situation, or without consulting a financial professional. Any opinions expressed herein are solely those of the author, and do not in any way represent the views or opinions of any other person or entity.

DecisionPoint is not a registered investment advisor. Investment and trading decisions are solely your responsibility. DecisionPoint newsletters, blogs or website materials should NOT be interpreted as a recommendation or solicitation to buy or sell any security or to take any specific action.

Helpful DecisionPoint Links:

Trend Models

Price Momentum Oscillator (PMO)

On Balance Volume

Swenlin Trading Oscillators (STO-B and STO-V)

ITBM and ITVM

SCTR Ranking

Bear Market Rules

previous post
Democrats’ furor over ‘unqualified’ Trump nominees puts Biden’s staffing decisions back in the spotlight
next post
Are the Magnificent 7 Still the Kings of Wall Street?

Related Posts

DP Trading Room: Magnificent Seven Earnings Preview

October 28, 2024

Riding the Stock Market’s Wave: How to Maximize...

November 13, 2024

It’s TOO EARLY to Be Bullish on Tesla

June 18, 2024

Why Technical Analysis Does NOT Work for Leveraged...

June 21, 2024

Market As Good As It Gets

December 9, 2024

S&P 500 Makes a New All-Time High By...

April 27, 2024

A Half Point Fed Rate Cut? The Stock...

September 13, 2024

Week Ahead: NIFTY Steps Into Next Week With...

January 11, 2025

These Breadth Charts PROVE How Strong This Bull...

March 29, 2024

The Best Five Sectors, #5

January 31, 2025

    Fill Out & Get More Relevant News


    Stay ahead of the market and unlock exclusive trading insights & timely news. We value your privacy - your information is secure, and you can unsubscribe anytime. Gain an edge with hand-picked trading opportunities, stay informed with market-moving updates, and learn from expert tips & strategies.

    Latest News

    • Israel releases conversations with Gaza residents amid criticisms of aid delivery system

      July 1, 2025
    • Iran, following Trump strikes, says ‘the doors of diplomacy will never slam shut’

      July 1, 2025
    • Elon Musk’s attacks on Trump’s ‘big, beautiful bill’ have ‘no basis,’ says No 2 House Republican

      July 1, 2025
    • Trump says DOGE ‘monster’ may have to ‘eat Elon’ as Musk vows primary ads for lawmakers who cross him on BBB

      July 1, 2025
    • Senate parliamentarian OKs ban on Planned Parenthood federal funding in Trump megabill

      July 1, 2025
    • 4 Senate amendments to Trump megabill that failed — and 1 that passed

      July 1, 2025

    Categories

    • Business (1,288)
    • Politics (6,227)
    • Stocks (904)
    • World News (460)
    • Privacy Policy
    • Terms & Conditions

    Disclaimer: insidersadvisor.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.

    Copyright © 2024 insidersadvisor.com | All Rights Reserved